 | Up a level |
Brooker, RC 
ORCID: 0000-0002-0668-6889, Hobkirk, A, Cashman, H, Sato, T, Broderick, D, Wong, H, Kyzas, P, Haridass, A, Sacco, JJ and Schache, AG ORCID: 0000-0001-9466-6038
(2021)
Adjuvant management of locally advanced oral squamous cell carcinoma – real world challenges and opportunities.
British Journal of Oral and Maxillofacial Surgery, 59 (8).
pp. 952-958.
Brooker, RC ORCID: 0000-0002-0668-6889, Sacco, JJ and Schache, AG ORCID: 0000-0001-9466-6038
(2019)
Integration of Checkpoint Inhibitors into the Management of Locally Advanced Head and Neck Cancer - Future Perspectives.
Clinical Oncology, 31 (7).
pp. 424-431.
Brooker, RC ORCID: 0000-0002-0668-6889, Schache, AG ORCID: 0000-0001-9466-6038 and Sacco, JJ
(2021)
NICO Phase II clinical trial - focus on an emerging immunotherapy strategy for the adjuvant treatment of locally-advanced oral cancers.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 59 (8).
pp. 959-962.